New‐onset guttate psoriasis secondary to COVID‐19

SARS‐CoV‐2, the virus that causes coronavirus disease 2019 (COVID‐19), is associated with flares of psoriasis in patients with well‐documented disease. Both viral infection and medications used for treatment, like hydroxychloroquine, were incriminated. Herein, we report the case of a 25‐year‐old mal...

Descripción completa

Detalles Bibliográficos
Autores principales: Rouai, Meriem, Rabhi, Faten, Mansouri, Nada, Jaber, Kahena, Dhaoui, Raouf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319378/
https://www.ncbi.nlm.nih.gov/pubmed/34336212
http://dx.doi.org/10.1002/ccr3.4542
_version_ 1783730434254831616
author Rouai, Meriem
Rabhi, Faten
Mansouri, Nada
Jaber, Kahena
Dhaoui, Raouf
author_facet Rouai, Meriem
Rabhi, Faten
Mansouri, Nada
Jaber, Kahena
Dhaoui, Raouf
author_sort Rouai, Meriem
collection PubMed
description SARS‐CoV‐2, the virus that causes coronavirus disease 2019 (COVID‐19), is associated with flares of psoriasis in patients with well‐documented disease. Both viral infection and medications used for treatment, like hydroxychloroquine, were incriminated. Herein, we report the case of a 25‐year‐old male patient who presented a first‐onset guttate psoriasis following a COVID‐19 infection. We have not found previous descriptions of de novo guttate psoriasis post‐COVID‐19.
format Online
Article
Text
id pubmed-8319378
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83193782021-07-31 New‐onset guttate psoriasis secondary to COVID‐19 Rouai, Meriem Rabhi, Faten Mansouri, Nada Jaber, Kahena Dhaoui, Raouf Clin Case Rep Case Report SARS‐CoV‐2, the virus that causes coronavirus disease 2019 (COVID‐19), is associated with flares of psoriasis in patients with well‐documented disease. Both viral infection and medications used for treatment, like hydroxychloroquine, were incriminated. Herein, we report the case of a 25‐year‐old male patient who presented a first‐onset guttate psoriasis following a COVID‐19 infection. We have not found previous descriptions of de novo guttate psoriasis post‐COVID‐19. John Wiley and Sons Inc. 2021-07-28 /pmc/articles/PMC8319378/ /pubmed/34336212 http://dx.doi.org/10.1002/ccr3.4542 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Report
Rouai, Meriem
Rabhi, Faten
Mansouri, Nada
Jaber, Kahena
Dhaoui, Raouf
New‐onset guttate psoriasis secondary to COVID‐19
title New‐onset guttate psoriasis secondary to COVID‐19
title_full New‐onset guttate psoriasis secondary to COVID‐19
title_fullStr New‐onset guttate psoriasis secondary to COVID‐19
title_full_unstemmed New‐onset guttate psoriasis secondary to COVID‐19
title_short New‐onset guttate psoriasis secondary to COVID‐19
title_sort new‐onset guttate psoriasis secondary to covid‐19
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319378/
https://www.ncbi.nlm.nih.gov/pubmed/34336212
http://dx.doi.org/10.1002/ccr3.4542
work_keys_str_mv AT rouaimeriem newonsetguttatepsoriasissecondarytocovid19
AT rabhifaten newonsetguttatepsoriasissecondarytocovid19
AT mansourinada newonsetguttatepsoriasissecondarytocovid19
AT jaberkahena newonsetguttatepsoriasissecondarytocovid19
AT dhaouiraouf newonsetguttatepsoriasissecondarytocovid19

Ejemplares similares